PSMA ligand targeted compounds and uses thereof
US12133901B2 · kind B2 · utility
0Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2020 |
| Grant date | Nov 5, 2024 |
| Priority date | — |
| Expiry date | Feb 20, 2042 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y30/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prostate-specific membrane antigen (PSMA) targeted compounds having formula (I), nanoclusters formed thereof, pharmaceutical compositions comprising a plurality of these compounds, and methods for treating and detecting cancers in a subject are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.